Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05572385

Clinic and Neurophysiology of Aphasia Treatment

Clinical and Neurophysiological Features of Neurorehabilitation Effects in Cerebrovascular Aphasia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Klinik Bavaria · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In the planned study, clinical and electrophysiological features of aphasia recovery in stroke patients are investigated.

Detailed description

Clinical neurorehabilitation faces a major challenge of functional recovery in aphasia, i.e. guiding the structural and temporal dynamics of reorganization within responsible neural networks. Here, according to current research, relevant neural factors affecting the treatment and thus the functional recovery of aphasia patients after stroke are of interest, highlighting structural as well as functional neuroanatomical features. Of particular interest are not only the functional localization of affected cerebral regions, but more the clinical and neurophysiological patterns which might help to factorize and predict the therapeutic outcome. In the planned study, the clinical and neurophysiological characteristics of the dynamics of language function recovery in relation to the intensity of professional speech therapy (constraint induced aphasia therapie - CIAT) will be recorded in 40 patients with aphasia resulting from a cerebrovascular event. The aim of this study is to test the value of neurophysiological aspects based on electroencephalographic (EEG) parameters such as event-related potentials (N400, P600, theta band activity) for the identification of specific neuronal markers, which in turn support predictive statements for individual therapy planning of logopedic treatment in neurorehabilitation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCIAT + Conventional neurorehabilitative therapyCIAT = Constrained induced aphasia therapy

Timeline

Start date
2023-07-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2022-10-07
Last updated
2022-10-07

Source: ClinicalTrials.gov record NCT05572385. Inclusion in this directory is not an endorsement.